Trials / Completed
CompletedNCT03602651
MAGZEN® Effect on Recent Anxiety Reaction
MAGZEN® Effect on Recent Anxiety Reaction (STRESS2)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Laboratoire Dielen · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Multicentres, observational study, prospective, to evaluate the effect of MAGZEN® in the treatment of recent anxiety reaction.
Detailed description
107 patients suffering from recent anxiety reaction will be included in the study. They will be treated by MAGZEN® during 4 weeks and we will study the effect of this treatment on the evolution of their anxiety after the cure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hamilton-anxiety scale (HAM-A) | Evolution of anxiety disorders is evaluated by the Hamilton-anxiety scale (HAM-A) |
Timeline
- Start date
- 2019-11-08
- Primary completion
- 2021-05-03
- Completion
- 2021-05-14
- First posted
- 2018-07-27
- Last updated
- 2021-08-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03602651. Inclusion in this directory is not an endorsement.